Search Results - "BOURBIGOT, Bernard"

Randomized double-blind study of immunoprophylaxis with basiliximab, a chimeric anti-interleukin-2 receptor monoclonal antibody, in combination with mycophenolate mofetil-containing triple therapy in renal transplantation by LAWEN, Joseph G, DAVIES, Elizabeth A, KORN, Alexander, GIRAULT, Danièle, MOURAD, Georges, OPPENHEIMER, Frederic, GONZALEZ MOLINA, Miguel, ROSTAING, Lionel, WILEINSON, Alan H, MULLOY, Laura L, BOURBIGOT, Bernard J, PRESTELE, Hans

“…Acute rejection remains a major problem in renal transplantation. Immunoprophylaxis with basiliximab (Simulect) has achieved significant reductions in acute…”
Get full text

Toxoplasmosis-associated hemophagocytic syndrome in renal transplantation by Segall, Liviu, Moal, Marie-Christine, Doucet, Laurent, Kergoat, Nathalie, Bourbigot, Bernard

“…Toxoplasmosis is an infrequent, often difficult to diagnose and potentially lethal disease in kidney transplant recipients. Among reported cases, a few were…”
Get more information

Thymoglobulin Induction and Sirolimus Versus Tacrolimus in Kidney Transplant Recipients Receiving Mycophenolate Mofetil and Steroids by GLOTZ, Denis, CHARPENTIER, Bernard, CHALOPIN, Jean-Marc, CASSUTO, Elisabeth, LEFRANCOIS, Nicole, ABRAMOVICZ, Daniel, LANG, Philippe, ROSTAING, Lionel, RIFLE, Gerard, VANRENTERGHEM, Yves, BERTHOUX, Francois, BOURBIGOT, Bernard, DELAHOUSSE, Michel

“…To define the role of mammalian target of rapamycin inhibitors in kidney transplantation, we compared efficacy and safety of two immunosuppressive regimens-a…”
Get full text

Everolimus with Optimized Cyclosporine Dosing in Renal Transplant Recipients: 6‐Month Safety and Efficacy Results of Two Randomized Studies by Vitko, Stefan, Tedesco, Helio, Eris, Josette, Pascual, Julio, Whelchel, John, Magee, John C., Campbell, Scott, Civati, Giovanni, Bourbigot, Bernard, Filho, Gentil Alves, Leone, John, Garcia, Valter Duro, Rigotti, Paolo, Esmeraldo, Ronaldo, Cambi, Vincenzo, Haas, Tomas, Jappe, Annette, Bernhardt, Peter, Geissler, Johanna, Cretin, Nathalie

“…Two prospective, randomized studies evaluated everolimus 1.5 vs. 3 mg/day with steroids and low‐exposure cyclosporine (CsA) (C2 monitoring) in de novo renal…”
Get full text

12-month safety and efficacy of everolimus with reduced exposure cyclosporine in de novo renal transplant recipients by Tedesco-Silva, Jr, Helio, Vitko, Stefan, Pascual, Julio, Eris, Josette, Magee, John C, Whelchel, John, Civati, Giovanni, Campbell, Scott, Alves-Filho, Gentil, Bourbigot, Bernard, Garcia, Valter Duro, Leone, John, Esmeraldo, Ronaldo, Rigotti, Paolo, Cambi, Vincenzo, Haas, Tomas

“…The proliferation signal inhibitor everolimus (Certican), has demonstrated efficacy with full-dose cyclosporine (CsA) (Neoral). Two multicenter randomized…”
Get more information

A three-arm study comparing immediate tacrolimus therapy with antithymocyte globulin induction therapy followed by tacrolimus or cyclosporine A in adult renal transplant recipients by CHARPENTIER, Bernard, ROSTAING, Lionel, WOLF, Philippe, CASSUTO, Elisabeth, MOULIN, Bruno, RIFLE, Gerard, PRUNA, André, MERVILLE, Pierre, MIGNON, Francoise, LEGENDRE, Christophe, LE POGAMP, Patrick, LEBRANCHU, Yvon, BERTHOUX, Francois, TOUPANCE, Olivier, DE LIGNY, Bruno Hurault, TOUCHARD, Guy, OLMER, Michel, PURGUS, Raj, POUTEIL-NOBLE, Claire, GLOTZ, Denis, BOURBIGOT, Bernard, LESKI, Michel, WAUTERS, Jean-Pierre, LANG, Philippe, KESSLER, Michèle, CIVATI, Giovanni, TOURAINE, Jean-Louis, SQUIFFLET, Jean-Paul, VIALTEL, Paul, ABRAMOWICZ, Daniel, MOURAD, Georges

“…Induction therapy with antithymocyte globulin (ATG) reduces the incidence of acute rejection after transplantation. A study was undertaken to assess the…”
Get full text

Impact of Cyclosporine Reduction With MMF: A Randomized Trial in Chronic Allograft Dysfunction. The ‘Reference’ Study by Frimat, L., Cassuto‐Viguier, E., Charpentier, B., Noël, C., Provôt, F., Rostaing, L., Glotz, D., Sraer, J. D., Bourbigot, B., Moulin, B., Lang, P., Ducloux, D., Pouteil‐Noble, C., Girardot‐Seguin, S., Kessler, M.

“…Long‐term use of calcineurine inhibitors (CNIs) may contribute to the development of chronic allograft dysfunction (CAD). We investigate the impact of the…”
Get full text

Efficacy and safety of enteric-coated mycophenolate sodium in renal transplant patients with diabetes mellitus: post hoc analyses from three clinical trials by Pietruck, Frank, Budde, Klemens, Salvadori, Maurizio, Sollinger, Hans, Bourbigot, Bernard, Gentil, Miguel Angel, Oppenheimer, Frederic

“…:  To examine the efficacy and safety of enteric‐coated mycophenolate sodium (EC‐MPS, myfortic®) in renal transplant patients with diabetes mellitus, six‐ and…”
Get full text

Incidence and management of anemia in renal transplantation: an observational-French study by Choukroun, Gabriel, Deray, Gilbert, Glotz, Denis, Lebranchu, Yvon, Dussol, Bertrand, Bourbigot, Bernard, Lefrançois, Nicole, Cassuto-Viguier, Elisabeth, Toupance, Olivier, Hacen, Chafik, Lang, Philippe, Mazouz, Hakim, Martinez, Franck

“…The management of anemia after kidney transplantation remains poorly explored. The Management of Anemia in French Kidney Transplant Patients (MATRIX) study is…”
Get full text

Renal function with delayed or immediate cyclosporine microemulsion in combination with enteric-coated mycophenolate sodium and steroids: results of follow up to 30 months post-transplant by Mourad, Georges, Karras, Alexandre, Kamar, Nassim, Garrigue, Valérie, Legendre, Christophe, Lefrançois, Nicole, Charpentier, Bernard, Bourbigot, Bernard, Pouteil-Noble, Claire, Bayle, François, Lebranchu, Yvon, Mariat, Christophe, Meur, Yann Le, Kessler, Michèle, Moulin, Bruno, Ducloux, Didier, Delahousse, Michel, Lang, Philippe, Merville, Pierre, Chaouche-Teyara, Kamel, Rostaing, Lionel

“…:  Background:  In the multicenter, open‐label Myriade study, renal transplant patients were randomized to early cyclosporine microemulsion (CsA‐ME, day 0) or…”
Get full text

Tolerability of Enteric-Coated Mycophenolate Sodium to 1 Year in Combination With Cyclosporine and Corticosteroids in Renal Transplant Recipients by Rostaing, L., Mourad, G., Kamar, N., Garrigue, V., Karras, A., Lefrançois, N., Charpentier, B., Bourbigot, B., Pouteil-Noble, C., Bayle, F., Lebranchu, Y., Berthoux, F., Le Meur, Y., Kessler, M., Moulin, B., Ducloux, D., Delahousse, M., Lang, P., Merville, P., Chaouche-Teyara, K., Legendre, C.

“…Enteric-coated mycophenolate sodium (EC-MPS) is therapeutically equivalent to mycophenolate mofetil, but delays release of mycophenolic acid until it reaches…”
Get full text

Premier episode de rejet aigu apres transplantation renale: etude des caracteristiques histopathologiques en fonction du risque immunologique du patient by Ghisdal, Lidia, Touchard, Guy, Goujon, Jean-Michel, Buob, David, Durand, Dominique, Mourad, Georges, Lang, Philippe, Kessler, Michele, Snanoudj, Renaud, Berthoux, Francois, Merville, Pierre, Ouali, Nacera, Squifflet, Jean-Paul, Bayle, Francois, Bourgeon, Bruno, Rifle, Gerard, Peeters, Patrick, Delahousse, Michel, Legendre, Christophe, Bourbigot, Bernard, Noel, Christian, Abramowicz, Daniel

“…Renal allograft biopsies (n=34) of two different populations of patients according to the immunological risk (high versus low-risk) have been compared…”
Get full text

First acute rejection episode after renal transplantation: study of the histopathological characteristics according to the immunological risk by Ghisdal, Lidia, Touchard, Guy, Goujon, Jean-Michel, Buob, David, Durand, Dominique, Mourad, Georges, Lang, Philippe, Kessler, Michele, Snanoudj, Renaud, Berthoux, François, Merville, Pierre, Ouali, Nacéra, Squifflet, Jean-Paul, Bayle, François, Bourgeon, Bruno, Rifle, Gérard, Peeters, Patrick, Delahousse, Michel, Legendre, Christophe, Bourbigot, Bernard, Noël, Christian, Abramowicz, Daniel

“…Renal allograft biopsies (n=34) of two different populations of patients according to the immunological risk (high versus low-risk) have been compared…”
Get full text

Randomized double-blind study of immunoprophylaxis with basiliximab, a chimeric anti-interleukin-2 receptor monoclonal antibody, in combination with mycophenolate mofetil-containing triple therapy in renal transplantation12 by Lawen, Joseph G., Davies, Elizabeth A., Mourad, Georges, Oppenheimer, Frederic, Molina, Miguel Gonzalez, Rostaing, Lionel, Wilkinson, Alan H., Mulloy, Laura L., Bourbigot, Bernard J., Prestele, Hans, Korn, Alexander, Girault, Dani??le

Get full text

A three-arm study comparing immediate tacrolimus therapy with antithymocyte globulin induction therapy followed by tacrolimus or cyclosporine A in adult renal transplant recipients1 by Charpentier, Bernard, Rostaing, Lionel, Berthoux, Francois, Lang, Philippe, Civati, Giovanni, Touraine, Jean-Louis, Squifflet, Jean-Paul, Vialtel, Paul, Abramowicz, Daniel, Mourad, Georges, Wolf, Philippe, Cassuto, Elisabeth, Moulin, Bruno, Rifle, Gerard, Pruna, Andr??, Merville, Pierre, Mignon, Fran??oise, Legendre, Christophe, Le Pogamp, Patrick, Lebranchu, Yvon, Toupance, Olivier, Hurault de Ligny, Bruno, Touchard, Guy, Olmer, Michel, Purgus, Raj, Pouteil-Noble, Claire, Glotz, Denis, Bourbigot, Bernard, Leski, Michel, Wauters, Jean-Pierre, Kessler, Mich??le

Get full text

Incidence et prise en charge de l’anémie en transplantation rénale : une étude observationnelle française by Choukroun, Gabriel, Deray, Gilbert, Glotz, Denis, Lebranchu, Yvon, Dussol, Bertrand, Bourbigot, Bernard, Lefrançois, Nicole, Cassuto-Viguier, Elisabeth, Toupance, Olivier, Hacen, Chafik, Lang, Philippe, Mazouz, Hakim, Martinez, Franck

“…Les conséquences de l’anémie chez le patient transplanté rénal n’ont pas été bien évaluées. Cela explique certainement la prévalence élevée de l’anémie chez…”
Get full text

Effects of MHC-encoded TAP1 and TAP2 gene polymorphism and matching on kidney graft rejection by Chevrier, D, Giral, M, Braud, V, Bourbigot, B, Muller, J Y, Bignon, J D, Soulillou, J P

“…The products of TAP1 and TAP2 genes, recently mapped within the MHC class II region, are involved in antigen presentation by MHC class I molecules, especially…”
Get more information

Premier épisode de rejet aigu après transplantation rénale : étude des caractéristiques histopathologiques en fonction du risque immunologique du patient by Ghisdal, Lidia, Touchard, Guy, Goujon, Jean-Michel, Buob, David, Durand, Dominique, Mourad, Georges, Lang, Philippe, Kessler, Michele, Snanoudj, Renaud, Berthoux, François, Merville, Pierre, Ouali, Nacéra, Squifflet, Jean-Paul, Bayle, François, Bourgeon, Bruno, Rifle, Gérard, Peeters, Patrick, Delahousse, Michel, Legendre, Christophe, Bourbigot, Bernard, Noël, Christian, Abramowicz, Daniel

“…Renal allograft biopsies ( n = 34) of two different populations of patients according to the immunological risk (high versus low-risk) have been compared…”
Get full text

Prospective randomized comparison of University of Wisconsin and UW-modified, lacking hydroxyethyl-starch, cold-storage solutions in kidney transplantation by Baatard, R, Pradier, F, Dantal, J, Karam, G, Cantarovich, D, Hourmant, M, Bourbigot, B, Soulillou, J P

“…University of Wisconsin cold storage solution differs from Euro-Collins by the presence of adenosine, allopurinol, and hydroxyethyl starch, which maintains…”
Get more information

Oral water intoxication in babies by Tanneau, R S, Bourbigot, B

Get more information